171 related articles for article (PubMed ID: 37933639)
1. [Neutrophil-lymphocyte and platelet-lymphocyte ratios for assessing disease activity in patients with rheumatoid arthritis receiving tofacitinib treatment].
Tang J; Chen J; Lin G; Zhang H; Gui M; Li N; Gu Y; Luo L; Sun J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1651-1656. PubMed ID: 37933639
[TBL] [Abstract][Full Text] [Related]
2. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.
Sargin G; Senturk T; Yavasoglu I; Kose R
Int J Rheum Dis; 2018 Dec; 21(12):2122-2127. PubMed ID: 30338636
[TBL] [Abstract][Full Text] [Related]
3. The value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: A multicenter retrospective study.
Jin Z; Cai G; Zhang P; Li X; Yao S; Zhuang L; Ren M; Wang Q; Yu X
J Clin Lab Anal; 2021 Jan; 35(1):e23569. PubMed ID: 32951253
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis.
Fu H; Qin B; Hu Z; Ma N; Yang M; Wei T; Tang Q; Huang Y; Huang F; Liang Y; Yang Z; Zhong R
Clin Lab; 2015; 61(3-4):269-73. PubMed ID: 25974992
[TBL] [Abstract][Full Text] [Related]
5. Association between Hematological Indicesand Disease Activity in Patients with Rheumatoid Arthritis Treated with Janus Kinase Inhibitors for 24 Weeks.
Choe JY; Kim SK
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334603
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios may not be useful markers to assess disease activity in rheumatoid arthritis: A STROBE-compliant article.
Lijuan W; Yuting Z; Chaoyang L; Ju Y
Medicine (Baltimore); 2021 Nov; 100(45):e27631. PubMed ID: 34766563
[TBL] [Abstract][Full Text] [Related]
7. The Relationship between Hematological Markers of Systemic Inflammation (Neutrophil-To-Lymphocyte, Platelet-To-Lymphocyte, Lymphocyte-To-Monocyte Ratios) and Ultrasound Disease Activity Parameters in Patients with Rheumatoid Arthritis.
Targońska-Stępniak B; Zwolak R; Piotrowski M; Grzechnik K; Majdan M
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32858869
[TBL] [Abstract][Full Text] [Related]
8. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
[TBL] [Abstract][Full Text] [Related]
9. Relationship of hematologic markers with IL-17 and IL-1 beta in patients with rheumatoid arthritis.
Sağ S; Sağ MS; Tekeoğlu I; Kamanlı A; Nas K; Acar BA
J Back Musculoskelet Rehabil; 2018; 31(4):703-707. PubMed ID: 29578474
[TBL] [Abstract][Full Text] [Related]
10. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoid arthritis.
Peng YF; Cao L; Zeng YH; Zhang ZX; Chen D; Zhang Q; Zhu YS
Open Med (Wars); 2015; 10(1):249-253. PubMed ID: 28352702
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Platelets-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Rheumatoid Arthritis and Ankylosing Spondylitis.
Khan S; Yousaf MJ; Rashid A; Manzar A
J Coll Physicians Surg Pak; 2024 Jan; 34(1):68-72. PubMed ID: 38185964
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib.
Bird P; Hall S; Nash P; Connell CA; Kwok K; Witcombe D; Thirunavukkarasu K
RMD Open; 2019; 5(1):e000742. PubMed ID: 30886732
[TBL] [Abstract][Full Text] [Related]
13. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
Uslu AU; Küçük A; Şahin A; Ugan Y; Yılmaz R; Güngör T; Bağcacı S; Küçükşen S
Int J Rheum Dis; 2015 Sep; 18(7):731-5. PubMed ID: 25900081
[TBL] [Abstract][Full Text] [Related]
14. Association between Novel Hematological Indices and Measures of Disease Activity in Patients with Rheumatoid Arthritis.
Choe JY; Lee CU; Kim SK
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676741
[TBL] [Abstract][Full Text] [Related]
15. Correlation of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and mean platelet volume (MPV) with gout activity: A monocentric and retrospective study.
Wu H; Zhou H; Chen P
Medicine (Baltimore); 2022 Sep; 101(35):e30242. PubMed ID: 36107534
[TBL] [Abstract][Full Text] [Related]
16. Overlooked hematological markers of disease activity in rheumatoid arthritis.
Tekeoğlu İ; Gürol G; Harman H; Karakeçe E; Çiftçi İH
Int J Rheum Dis; 2016 Nov; 19(11):1078-1082. PubMed ID: 26620362
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD).
Li P; Xia C; Liu P; Peng Z; Huang H; Wu J; He Z
BMC Nephrol; 2020 Nov; 21(1):511. PubMed ID: 33238906
[TBL] [Abstract][Full Text] [Related]
18. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio associated with disease activity in patients with Takayasu's arteritis: a case-control study.
Pan L; Du J; Li T; Liao H
BMJ Open; 2017 May; 7(4):e014451. PubMed ID: 28473512
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-lymphocyte and platelet-lymphocyte rate and their seasonal differences in ankylosing spondylitis and rheumatoid arthritis patients using anti-TNF medication.
Enginar AU; Kacar C
Bratisl Lek Listy; 2019; 120(8):586-592. PubMed ID: 31379182
[TBL] [Abstract][Full Text] [Related]
20. Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Lymphocyte Ratios as Biomarkers in Patients with Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Chen Q; Chen DY; Xu XZ; Liu YY; Yin TT; Li D
Med Sci Monit; 2019 Aug; 25():6474-6481. PubMed ID: 31462627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
